Literature DB >> 24800805

Impact of short-term liquid storage on human CD133(+) stem cells.

Cornelia A Lux1, Peter Mark, Christian Klopsch, Michael Laupheimer, Hoang Tu-Rapp, Wenzhong Li, Nan Ma, Gustav Steinhoff, Robert David.   

Abstract

Stem cell transplantation is a viable strategy for regenerative medicine. However, it is inevitable to have cells undergo storage for several hours or days due to processing and transportation. Therefore, it is crucial to have rigidly controlled conditions ensuring the therapeutic benefit of isolated stem cells. In the present study, we investigated the impact of short-term storage on human CD133(+) cells. CD133(+) cells were isolated from human bone marrow and kept at standardized nonfreezing storage conditions for up to 72 h. Cell viability (apoptosis/necrosis) and expression of CD133 and CXCR4 were analyzed by flow cytometry. Metabolic activity was determined using an MTT assay; colony-forming ability, as well as endothelial-like differentiation, was further evaluated. A qRT-PCR array was employed to investigate the expression of stemness genes. CD133 and CXCR4 expressions were preserved at all time points. After 30 h, cell number and metabolic activity decreased, although no significant changes were detected in cell viability and proliferation as well as endothelial-like differentiation. Cell viability and proliferation decreased significantly only after 72 h of storage. Our results indicate that storage of isolated human CD133(+) bone marrow stem cells in liquid allows for high viability and functionality. However, storage time should be limited in order to avoid cell loss.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24800805     DOI: 10.3727/096368914X681577

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  3 in total

1.  Magnet-Bead Based MicroRNA Delivery System to Modify CD133+ Stem Cells.

Authors:  Paula Müller; Natalia Voronina; Frauke Hausburg; Cornelia A Lux; Frank Wiekhorst; Gustav Steinhoff; Robert David
Journal:  Stem Cells Int       Date:  2016-10-04       Impact factor: 5.443

2.  GMP-conformant on-site manufacturing of a CD133+ stem cell product for cardiovascular regeneration.

Authors:  Anna Skorska; Paula Müller; Ralf Gaebel; Jana Große; Heiko Lemcke; Cornelia A Lux; Manuela Bastian; Frauke Hausburg; Nicole Zarniko; Sandra Bubritzki; Ulrike Ruch; Gudrun Tiedemann; Robert David; Gustav Steinhoff
Journal:  Stem Cell Res Ther       Date:  2017-02-10       Impact factor: 6.832

3.  Angiogenic Potential of Bone Marrow Derived CD133+ and CD271+ Intramyocardial Stem Cell Trans- Plantation Post MI.

Authors:  Sarah Sasse; Anna Skorska; Cornelia Aquilina Lux; Gustav Steinhoff; Robert David; Ralf Gaebel
Journal:  Cells       Date:  2019-12-27       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.